Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology Market Cap

Pyxis Oncology has a market cap or net worth of $241.83 million as of April 19, 2024. Its market cap has increased by 80.61% in one year.

• Market Cap: 241.83M
• Enterprise Value: 152.28M
• 1-Year Change: 80.61%
• Ranking: #3488
• Category: Micro-Cap
• Stock Price: $4.16

Market Cap Chart

Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $241.83M, a decrease of -53.83%. That is a compound annual growth rate of -26.16%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	263.30M	-6.23%
Apr 17, 2024	280.80M	3.01%
Apr 16, 2024	272.60M	-1.09%
Apr 15, 2024	275.60M	-3.64%
Apr 12, 2024	286.00M	-6.66%
Apr 11, 2024	306.40M	3.76%
Apr 10, 2024	295.30M	-5.05%
Apr 9, 2024	311.00M	-4.13%
Apr 8, 2024	324.40M	2.21%
Apr 5, 2024	317.40M	6.22%
Apr 4, 2024	298.80M	-7.72%
Apr 3, 2024	323.80M	3.52%
Apr 2, 2024	312.80M	12.32%
Apr 1, 2024	278.50M	12.48%
Mar 28, 2024	247.60M	1.39%
Mar 27, 2024	244.20M	9.65%
Mar 26, 2024	222.70M	4.95%
Mar 25, 2024	212.20M	-8.53%
Mar 22, 2024	232.00M	-19.53%
Mar 21, 2024	288.30M	19.78%
Mar 20, 2024	240.70M	5.43%
Mar 19, 2024	228.30M	5.11%
Mar 18, 2024	217.20M	-4.28%
Mar 15, 2024	226.90M	8.00%
Mar 14, 2024	210.10M	-11.39%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Q32 Bio	287.74M
Inozyme Pharma	287.24M
Pulmonx	286.33M
Prelude Therapeutics	283.28M
XOMA Corporation	281.93M
RAPT Therapeutics	279.77M
Erasca	278.75M
Verastem	274.20M